AbbVie Exercises Exclusive Right, Completes Acquisition Of Mitokinin
Biopharma major AbbVie Inc. (ABBV) announced on Thursday that it had exercised its exclusive right and completed the acquisition of Mitokinin, a biotechnology company.
Source: rttnews.com